Literature DB >> 15902534

Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections.

G L Petrikkos1, S A Christofilopoulou, N K Tentolouris, E A Charvalos, C J Kosmidis, G L Daikos.   

Abstract

The study presented here was conducted to determine the diagnostic value of measuring procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections. The sensitivity and specificity of these measurements ranged from 35% to 97%. On days 1 and 3 following the onset of fever, both serum procalcitonin and C-reactive protein levels were lower in patients with fungal infections than in those with bacterial infections (p<0.0001). The presence of mannan antigens combined with a procalcitonin level <0.5 ng/ml provided higher specificity for distinguishing fungal from bacterial infections than each result alone.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902534     DOI: 10.1007/s10096-005-1312-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

1.  Practice guidelines for the treatment of fungal infections. For the Mycoses Study Group. Infectious Diseases Society of America.

Authors:  J D Sobel
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

2.  Failure of PCT to indicate severe fungal infection in two immunodeficient patients.

Authors:  W Huber; U Schweigart; P Bottermann
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

3.  Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients.

Authors:  Raoul Herbrecht; Valérie Letscher-Bru; Corina Oprea; Bruno Lioure; Jocelyn Waller; France Campos; Odile Villard; Kun-Lun Liu; Shanti Natarajan-Amé; Patrick Lutz; Patrick Dufour; Jean-Pierre Bergerat; Ermanno Candolfi
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

4.  High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis.

Authors:  Y Gérard; D Hober; S Petitjean; M Assicot; C Bohuon; Y Mouton; P Wattré
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

5.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Authors:  S Ascioglu; J H Rex; B de Pauw; J E Bennett; J Bille; F Crokaert; D W Denning; J P Donnelly; J E Edwards; Z Erjavec; D Fiere; O Lortholary; J Maertens; J F Meis; T F Patterson; J Ritter; D Selleslag; P M Shah; D A Stevens; T J Walsh
Journal:  Clin Infect Dis       Date:  2001-11-26       Impact factor: 9.079

6.  New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis.

Authors:  B Sendid; M Tabouret; J L Poirot; D Mathieu; J Fruit; D Poulain
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

7.  Could procalcitonin be a predictive biological marker in systemic fungal infections?. Study of 14 cases.

Authors:  Sofia Christofilopoulou; Ekatherina Charvalos; George Petrikkos
Journal:  Eur J Intern Med       Date:  2002-12       Impact factor: 4.487

8.  Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection.

Authors:  Monique A S H Mennink-Kersten; Rocus R Klont; Adilia Warris; Huub J M Op den Camp; Paul E Verweij
Journal:  Lancet       Date:  2004-01-24       Impact factor: 79.321

9.  Serum procalcitonin rise is only slight in two cases of disseminated aspergillosis.

Authors:  G Beaune; F Bienvenu; C Pondarré; G Monneret; J Bienvenu; G Souillet
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

Review 10.  Impact of diagnostic markers on early antifungal therapy.

Authors:  Brian L Jones; Lorna A McLintock
Journal:  Curr Opin Infect Dis       Date:  2003-12       Impact factor: 4.915

View more
  10 in total

1.  Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients.

Authors:  Pierre Emmanuel Charles; Frédéric Dalle; Serge Aho; Jean-Pierre Quenot; Jean-Marc Doise; Hervé Aube; Nils-Olivier Olsson; Bernard Blettery
Journal:  Intensive Care Med       Date:  2006-08-08       Impact factor: 17.440

2.  Invasive fungal infection in Chinese patients with systemic lupus erythematosus.

Authors:  Guang-liang Chen; Yi Chen; Chang-qing Zhu; Cheng-de Yang; Shuang Ye
Journal:  Clin Rheumatol       Date:  2012-04-04       Impact factor: 2.980

Review 3.  Developments for improved diagnosis of bacterial bloodstream infections.

Authors:  A J M Loonen; P F G Wolffs; C A Bruggeman; A J C van den Brule
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-22       Impact factor: 3.267

4.  Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients.

Authors:  Markéta Marková; Helena Brodská; Karin Malíčková; Veronika Válková; Petr Cetkovský; Michal Kolář; Martin Haluzík
Journal:  Support Care Cancer       Date:  2013-05-28       Impact factor: 3.603

5.  Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever?

Authors:  James Owen Robinson; Frédéric Lamoth; Frank Bally; Marlies Knaup; Thierry Calandra; Oscar Marchetti
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

Review 6.  Significance of serum procalcitonin as biomarker for detection of bacterial peritonitis: a systematic review and meta-analysis.

Authors:  Shi-kun Yang; Li Xiao; Hao Zhang; Xiao-xuan Xu; Pan-ai Song; Fu-you Liu; Lin Sun
Journal:  BMC Infect Dis       Date:  2014-08-22       Impact factor: 3.090

7.  Low Levels of Procalcitonin or Presepsin Combined with Significantly Elevated C-reactive Protein May Suggest an Invasive Fungal Infection in Hematological Patients With Febrile Neutropenia.

Authors:  Igor Stoma; Igor Karpov; Anatoly Uss; Svetlana Krivenko; Igor Iskrov; Natalia Milanovich; Svetlana Vlasenkova; Irina Lendina; Kristina Belyavskaya; Veranika Charniak
Journal:  Hemasphere       Date:  2019-01-08

8.  Clinical features of invasive fungal disease in children with no underlying disease.

Authors:  Juan Huang; Chentao Liu; Xiangrong Zheng
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

9.  Biomarkers and molecular analysis to improve bloodstream infection diagnostics in an emergency care unit.

Authors:  Anne J M Loonen; Cornelis P C de Jager; Janna Tosserams; Ron Kusters; Mirrian Hilbink; Peter C Wever; Adriaan J C van den Brule
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

10.  Diagnostic efficacy of serum cytokines and chemokines in fungal bloodstream infection in febrile patients.

Authors:  Qi Wang; Ming Yang; Chi Wang; Jiayue Cui; Xinjun Li; Chengbin Wang
Journal:  J Clin Lab Anal       Date:  2020-01-23       Impact factor: 2.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.